Literature DB >> 377965

The use of exchange transfusions: a potentially useful adjunct in the treatment of fulminant falciparum malaria.

R L Nielsen, R B Kohler, W Chin, L J McCarthy, F C Luft.   

Abstract

Fulminant falciparum malaria with greater than 500,000/mm3 parasites in the peripheral blood portends a poor prognosis. We recently managed a patient who had greater than 1.2 million/mm3 parasitized erythrocytes in her peripheral blood, following initially inadequate antimalarial therapy, with exchange transfusion in addition to conventional chemotherapy. This patient recovered from her disease despite severe cerebral involvement and acute failure. We feel that exchange transfusion was a useful adjunct and should be considered in patients with life threatening falciparum malaria when conventional measures fail to control the disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 377965

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  6 in total

1.  Exchange transfusion for severe falciparum malaria?

Authors:  E C Reisinger; H L Silly; K H Smolle; G J Krejs
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

2.  Cerebral malaria, acute renal failure and disseminated intravascular coagulation.

Authors:  C D Buckner
Journal:  West J Med       Date:  1982-06

3.  Complicated chloroquine-resistant malaria.

Authors:  B R Thapa; S Mehta; L M Singh
Journal:  Indian J Pediatr       Date:  1985 Mar-Apr       Impact factor: 1.967

4.  Current concepts in the treatment of malaria in children.

Authors:  B R Thapa; R K Marwaha
Journal:  Indian J Pediatr       Date:  1984 Sep-Oct       Impact factor: 1.967

5.  Exchange transfusion in a case of severe Plasmodium falciparum infection: a case report.

Authors:  P Brill-Edwards; J S Keystone
Journal:  Can Fam Physician       Date:  1989-10       Impact factor: 3.275

6.  Inoculum effect with chloroquine and Plasmodium falciparum.

Authors:  I Y Gluzman; P H Schlesinger; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.